Bruker’s Q4 Revenue Beats, EPS Miss Spurs Jefferies Target Cut to $50
Bruker reported Q4 2025 revenue of $977.2 million, outperforming the consensus estimate of $966.4 million by 1.12% despite a 0.2% year-over-year sales decline. However, EPS of $0.59 missed the $0.65 estimate by 9.23%, prompting Jefferies to cut its price target to $50 from $55.
1. Q4 2025 Revenue Performance
Bruker generated $977.2 million in Q4 2025 revenue, a 0.2% decline from the prior year but 1.12% above the consensus estimate of $966.4 million. This marks the fourth consecutive quarter of revenue outperformance, underscoring strength in its scientific instruments and analytical solutions segments.
2. EPS Shortfall and Margin Pressure
The company reported EPS of $0.59, missing the estimate of $0.65 by 9.23% and down from $0.76 in Q4 2024. The decline highlights ongoing challenges in cost control and profit margin maintenance within its competitive industry.
3. Price Target Cut and Market Reaction
Jefferies reduced its price target from $55 to $50 following the mixed results, despite the stock’s current trading price of $37.51 implying over 33% upside. Recent trading saw an 11.6% drop, with a 52-week high of $56.22, low of $28.53, and a market capitalization of approximately $5.7 billion on volume of 7.17 million shares.